<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E"><gtr:id>598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E</gtr:id><gtr:name>Friedrich-Alexander University</gtr:name><gtr:address><gtr:line1>Schlossplatz 4</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B4B67041-2B73-4786-BDA5-20CA8E9BF709"><gtr:id>B4B67041-2B73-4786-BDA5-20CA8E9BF709</gtr:id><gtr:name>University of Kansas</gtr:name><gtr:address><gtr:line1>University of Kansas</gtr:line1><gtr:line4>Lawrence</gtr:line4><gtr:line5>Kansas</gtr:line5><gtr:postCode>KS 66045</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C5F5DCA-59E7-4987-AE32-A75A36944391"><gtr:id>9C5F5DCA-59E7-4987-AE32-A75A36944391</gtr:id><gtr:name>Nantes University</gtr:name><gtr:address><gtr:line1>Nantes University</gtr:line1><gtr:line2>1 Quai de Tourville</gtr:line2><gtr:line3>BP 13522</gtr:line3><gtr:line4>Nantes</gtr:line4><gtr:line5>F-44035</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A3C8BDDA-C539-4B60-B80C-EFD9B1165849"><gtr:id>A3C8BDDA-C539-4B60-B80C-EFD9B1165849</gtr:id><gtr:name>Salk Institute for Biological Studies</gtr:name><gtr:address><gtr:line1>Salk Institute for Biological Studies</gtr:line1><gtr:line2>PO Box 85800</gtr:line2><gtr:postCode>CA 92186 5</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/44CDAA37-A000-4CC6-B623-C2C78D4F916B"><gtr:id>44CDAA37-A000-4CC6-B623-C2C78D4F916B</gtr:id><gtr:name>MRC Virology Unit</gtr:name><gtr:address><gtr:line1>Glasgow University</gtr:line1><gtr:line2>Church Street</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G11 5JR</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/44CDAA37-A000-4CC6-B623-C2C78D4F916B"><gtr:id>44CDAA37-A000-4CC6-B623-C2C78D4F916B</gtr:id><gtr:name>MRC Virology Unit</gtr:name><gtr:address><gtr:line1>Glasgow University</gtr:line1><gtr:line2>Church Street</gtr:line2><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G11 5JR</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E"><gtr:id>598EC0B6-AEB9-4323-95F7-5B4EFCDDF33E</gtr:id><gtr:name>Friedrich-Alexander University</gtr:name><gtr:address><gtr:line1>Schlossplatz 4</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B4B67041-2B73-4786-BDA5-20CA8E9BF709"><gtr:id>B4B67041-2B73-4786-BDA5-20CA8E9BF709</gtr:id><gtr:name>University of Kansas</gtr:name><gtr:address><gtr:line1>University of Kansas</gtr:line1><gtr:line4>Lawrence</gtr:line4><gtr:line5>Kansas</gtr:line5><gtr:postCode>KS 66045</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C5F5DCA-59E7-4987-AE32-A75A36944391"><gtr:id>9C5F5DCA-59E7-4987-AE32-A75A36944391</gtr:id><gtr:name>Nantes University</gtr:name><gtr:address><gtr:line1>Nantes University</gtr:line1><gtr:line2>1 Quai de Tourville</gtr:line2><gtr:line3>BP 13522</gtr:line3><gtr:line4>Nantes</gtr:line4><gtr:line5>F-44035</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>France</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A3C8BDDA-C539-4B60-B80C-EFD9B1165849"><gtr:id>A3C8BDDA-C539-4B60-B80C-EFD9B1165849</gtr:id><gtr:name>Salk Institute for Biological Studies</gtr:name><gtr:address><gtr:line1>Salk Institute for Biological Studies</gtr:line1><gtr:line2>PO Box 85800</gtr:line2><gtr:postCode>CA 92186 5</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/94FE74C9-8F1B-4763-8BCD-35CBD425778B"><gtr:id>94FE74C9-8F1B-4763-8BCD-35CBD425778B</gtr:id><gtr:firstName>Roger</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Everett</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U130169966"><gtr:id>AE6C0863-45E5-4CD9-9A62-33B4D7782911</gtr:id><gtr:title>Regulation of the initial stages of herpes simplex virus lytic infection and reactivation from latency</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U130169966</gtr:grantReference><gtr:abstractText>Herpes simplex virus type 1 (HSV-1) is one of several herpesviruses that infect a high proportion of the human population. Although these viruses do not generally cause dangerous diseases, herpesvirus infections can become serious or even fatal in the newborn and those with damaged immune systems. Genital herpes simplex virus infections are one of the most common sexually transmitted diseases. Herpesviruses are common because after an initial infection they attain a latent state and are carried by the individual for life. As there are no treatments to eradicate latent virus, an understanding of how herpesviruses attain, maintain and reactivate from latency is necessary for improved treatments for herpesvirus diseases. Current research aims to elucidate the molecular mechanisms by which lytic and latent HSV-1 infection are regulated. HSV-1 encodes regulatory proteins that interact with cellular proteins and control systems, either interfering with or hijacking them to serve the needs of the virus. An understanding of these processes will reveal new possibilities for interfering with virus growth and reactivation from latency. Our results will contribute to improved understanding of processes that are important for normal and cancerous cells. The work is laboratory-based and involves biochemistry, molecular biology, microscopy and infection of cultured cells.</gtr:abstractText><gtr:technicalSummary>There are several herpesviruses that infect a high proportion of the human population. Although these viruses do not generally cause dangerous diseases, in certain groups of people, particularly the newborn and those with damaged immune systems, herpesvirus infections can become serious or even fatal. Herpesviruses are common because after an initial episode of infection, they attain a latent state so that they are carried by the infected individual for life. As there are no treatments to eradicate latent virus, an understanding of the molecular mechanisms by which herpesviruses attain, maintain and reactivate from latency is necessary for improved treatments for herpesvirus diseases. The balance between latent and lytic herpesvirus infections is governed by both viral and cellular factors, and by antiviral mechanisms that include not only the various arms of the immune defence but also mechanisms that operate via constitutively expressed proteins at the cellular level. This latter phenomenon, which is a relatively recent concept, is known as intrinsic immunity, intrinsic antiviral defence, or intrinsic resistance.

The principle aim of this programme is to decipher the mechanisms of action of herpes simplex virus type 1 (HSV-1) regulatory protein ICP0, which is required for efficient initiation of lytic infection and reactivation of latent virus. The main role of ICP0 is in counteracting intrinsic antiviral defence. We have shown that ICP0 is a ubiquitin E3 ligase that targets cellular intrinsic resistance proteins for destruction by the proteasome pathway. Current research aims to define the mechanisms of substrate targeting by ICP0 and to correlate these activities with the role of ICP0 in the regulation of viral infection. Our approaches utilise cultured cell systems of virus infection. 
A major target of ICP0 is the cellular protein PML, a component of nuclear sub-structures known as PML Nuclear Bodies (PML NBs). PML and other PML NB proteins are rapidly recruited to sites associated with infecting HSV-1 genomes, a process that represents an intrinsic cellular response that represses viral gene expression. An important role of ICP0 is to inactivate this response to allow efficient infection. We have determined the molecular basis of the recruitment of PML to HSV-1 genomes and we have found that this mechanism underlies the recruitment of a number of other cellular proteins. We are extending these studies to the regulatory proteins of other herpesviruses, in particular human cytomegalovirus, to determine how their functions and mechanisms of action relate to those of ICP0. The results are expected to increase understanding of processes common to several DNA viral infections. Since components of PML NBs have been implicated in many important cellular control pathways, our experiments are likely to contribute to many aspects of cell biology research.</gtr:technicalSummary><gtr:fund><gtr:end>2013-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-08-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>3627126</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Gene Regulation and Expression</gtr:department><gtr:description>SUMO proteome study</gtr:description><gtr:id>06FD78DA-1CB5-4A7B-880D-CDEFBBE80631</gtr:id><gtr:impact>Publications will ensue in due course</gtr:impact><gtr:outcomeId>nMm89LbHTHp-1</gtr:outcomeId><gtr:partnerContribution>Design of study, experimentation, data analysis</gtr:partnerContribution><gtr:piContribution>Design of study, experimentation, data analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nantes</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>INSERM U649 (Gene Therapy Laboratory)</gtr:department><gtr:description>AAV ICP0 reactivation</gtr:description><gtr:id>58DD222E-F0ED-409F-B5EE-D3D5E32352E9</gtr:id><gtr:impact>PMID 16537633</gtr:impact><gtr:outcomeId>0E288450D7D-1</gtr:outcomeId><gtr:partnerContribution>Provision of research reagents</gtr:partnerContribution><gtr:piContribution>Most of the experimentation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Biomolecular Sciences</gtr:department><gtr:description>STAT1 and IRF3 study</gtr:description><gtr:id>7B19E42C-EFD9-4FE5-B0AC-EB67A7270AC2</gtr:id><gtr:impact>PMID 18579584</gtr:impact><gtr:outcomeId>1F9862FAF95-1</gtr:outcomeId><gtr:partnerContribution>provision of research reagents</gtr:partnerContribution><gtr:piContribution>most of the experimentation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Salk Institute for Biological Studies</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Laboratory of Genetics Salk</gtr:department><gtr:description>ICP0 and DNA repair</gtr:description><gtr:id>378DEDB0-DCB0-425C-BB0C-07BFD7BCC5DC</gtr:id><gtr:impact>PMID 20075863
PMID 21698222</gtr:impact><gtr:outcomeId>tQUik3uuYg7-1</gtr:outcomeId><gtr:partnerContribution>Provision and exchange of reagents</gtr:partnerContribution><gtr:piContribution>Provision and exchange of reagents</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>proteomics study</gtr:description><gtr:id>A5051C33-340D-40B8-997B-A465442CAE87</gtr:id><gtr:impact>PMID 19670248</gtr:impact><gtr:outcomeId>B7C7227FE8E-1</gtr:outcomeId><gtr:partnerContribution>They did a considerable amount of practical work and analysis</gtr:partnerContribution><gtr:piContribution>provision of samples, and later confirmatory analysis of results from a proteomics screen</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Friedrich-Alexander University Erlangen-Nuremberg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Clinical and Molecular Virology</gtr:department><gtr:description>PML depletion study</gtr:description><gtr:id>3AF2EBF3-6487-4037-B28B-AD89D030105E</gtr:id><gtr:impact>PMID 16873256</gtr:impact><gtr:outcomeId>A1F87F71FC0-1</gtr:outcomeId><gtr:partnerContribution>provision of research reagents</gtr:partnerContribution><gtr:piContribution>most of the experimentation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Friedrich-Alexander University Erlangen-Nuremberg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Dermatology</gtr:department><gtr:description>CD83 study</gtr:description><gtr:id>EF1F4A11-B40F-4ECE-BB7D-51A2F5987BA4</gtr:id><gtr:impact>PMID 17428858</gtr:impact><gtr:outcomeId>091FDD5F8BC-1</gtr:outcomeId><gtr:partnerContribution>experimental work</gtr:partnerContribution><gtr:piContribution>advice and provision of reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kansas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Molecular Biosciences</gtr:department><gtr:description>ICP0 phosphorylation study</gtr:description><gtr:id>6B9ECD51-F4BF-4E69-B28E-723446A1755B</gtr:id><gtr:impact>PMID 18715910</gtr:impact><gtr:outcomeId>54558F3E48A-1</gtr:outcomeId><gtr:partnerContribution>provision of research reagents and advice</gtr:partnerContribution><gtr:piContribution>most of the experimentation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>King's College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine KCL</gtr:department><gtr:description>BRCA1 study</gtr:description><gtr:id>FCE59725-9EDF-4681-B0FF-54BDD748D082</gtr:id><gtr:impact>PMID 16403807</gtr:impact><gtr:outcomeId>EDCADE92E28-1</gtr:outcomeId><gtr:partnerContribution>they did much of the experimentation</gtr:partnerContribution><gtr:piContribution>we did some specialist experimentation and provided advice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leibniz Association</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Heinrich Pette Institute, Leibniz Institute for Experimental Virology</gtr:department><gtr:description>HepaRG PML and Sp100 study</gtr:description><gtr:id>301F0914-7E7A-437F-93BC-F1C98CE121FC</gtr:id><gtr:impact>PMID 18160441</gtr:impact><gtr:outcomeId>FB5EA18557E-1</gtr:outcomeId><gtr:partnerContribution>provision of cell lines</gtr:partnerContribution><gtr:piContribution>most of the experimentation</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>MRC Virology Unit Schools day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>51715A15-5716-4090-9BF2-2AA0C8BF5E75</gtr:id><gtr:impact>An event in which pupils from several local schools receive instruction, demonstration and information on the work of the MRC Virology Unit and general issues in virology.

enhanced student interest in virology</gtr:impact><gtr:outcomeId>0B2C470584E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>154880</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EC Marie Curie Fellowship Award</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:fundingRef>PIEF-GA-2009- 251948</gtr:fundingRef><gtr:id>DAB035AE-5A78-4DBE-80DD-035D7B585E13</gtr:id><gtr:outcomeId>top7CgkBPTj0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>210000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EC SME-STREP contract FP6-037517 'TargetHerpes'</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:fundingRef>LSHG-CT-2006- 037517</gtr:fundingRef><gtr:id>4F5A50E9-4065-4AA4-85C6-F7D3F80E2D97</gtr:id><gtr:outcomeId>70D17A3A1120</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>128000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRCT Development Gap Funding</gtr:description><gtr:fundingOrg>MRC Technology (MRCT)</gtr:fundingOrg><gtr:id>0B6D735A-759F-43CA-A697-F724E88F4173</gtr:id><gtr:outcomeId>0563CA27D6A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Viruses, plasmids, antibodies and cell lines. We receive many tens of requests for various research tools every year, comprising literally hundreds of items.</gtr:description><gtr:id>E26A1804-F4DA-4627-B827-B807E7635ADB</gtr:id><gtr:impact>Many of our research tools are used by others in their subsequent publications. Far too many to list.</gtr:impact><gtr:outcomeId>316EF923F4B</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Viruses, plasmids, antibodies and cell lines.</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>73CADB65-891A-4670-8C2E-C7E4657D8839</gtr:id><gtr:title>Comparison of the biological and biochemical activities of several members of the alphaherpesvirus ICP0 family of proteins.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>bDpwYSy39bJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B75FD90-F91B-494E-A375-8536A9C549CC</gtr:id><gtr:title>Study of early events during herpes simplex virus type 1 infection by confocal microscopy.</gtr:title><gtr:parentPublicationTitle>Methods (San Diego, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1046-2023</gtr:issn><gtr:outcomeId>pm_13522_22_21855636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>285611BF-CD4E-48FA-9513-BE5E1A71C5A1</gtr:id><gtr:title>Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>60FB0E83592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C31FBE6D-19BD-422A-A906-4B2BC13489A5</gtr:id><gtr:title>Analysis of the functions of herpes simplex virus type 1 regulatory protein ICP0 that are critical for lytic infection and derepression of quiescent viral genomes.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>ED2EAF7619A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B21FDABB-EDDE-45F0-B2F1-FA0283CEDDC2</gtr:id><gtr:title>PML isoforms in response to arsenic: high-resolution analysis of PML body structure and degradation.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e2ed0d09267aa126354de3cadb8992f"><gtr:id>2e2ed0d09267aa126354de3cadb8992f</gtr:id><gtr:otherNames>Hands KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>544e61f7cd8114.81418437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>012CA89C-A544-40FD-94BF-DDFA13D56009</gtr:id><gtr:title>Components of promyelocytic leukemia nuclear bodies (ND10) act cooperatively to repress herpesvirus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18f8dd74e42a937004ef684e85e65d68"><gtr:id>18f8dd74e42a937004ef684e85e65d68</gtr:id><gtr:otherNames>Glass M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13522_22_23221561</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31422A43-0D3F-4C1D-AC29-F350DFA40F37</gtr:id><gtr:title>Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0174e08fa5793d8eb306670cc319622b"><gtr:id>0174e08fa5793d8eb306670cc319622b</gtr:id><gtr:otherNames>Lukashchuk V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>2E6BDC3E5F8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BDDBD52-F02E-4D2E-9718-32E3ACCD961D</gtr:id><gtr:title>Herpes simplex virus type 1 induces CD83 degradation in mature dendritic cells with immediate-early kinetics via the cellular proteasome.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07da15fcf0e482d2dd63556c6af84081"><gtr:id>07da15fcf0e482d2dd63556c6af84081</gtr:id><gtr:otherNames>Kummer M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>97EB9C0645C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE4A7E97-15F9-4A7C-A42D-5D54515E44EB</gtr:id><gtr:title>Identification of a novel higher molecular weight isoform of USP7/HAUSP that interacts with the Herpes simplex virus type-1 immediate early protein ICP0.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2723c12ff0727de67ab75d967fb86e8"><gtr:id>d2723c12ff0727de67ab75d967fb86e8</gtr:id><gtr:otherNames>Antrobus R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>F65CCEF9C62</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5052EDF-0076-4126-A970-2D02FD578ED5</gtr:id><gtr:title>Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad25c84eb3b9c3ef2f116e146bbabaa2"><gtr:id>ad25c84eb3b9c3ef2f116e146bbabaa2</gtr:id><gtr:otherNames>Jurak I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>544e61f8412699.62440871</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6153F7F0-829A-4957-949A-4192A7787265</gtr:id><gtr:title>The intrinsic antiviral defense to incoming HSV-1 genomes includes specific DNA repair proteins and is counteracted by the viral protein ICP0.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0163656c5a6d8dd256ac7fa3d6835c52"><gtr:id>0163656c5a6d8dd256ac7fa3d6835c52</gtr:id><gtr:otherNames>Lilley CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>PqQ3MLDG9H9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED4F2064-B24A-44FE-BA05-D86837D0DBE4</gtr:id><gtr:title>SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML.</gtr:title><gtr:parentPublicationTitle>Oncogene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0836575655213b57e2f7218861f281ad"><gtr:id>0836575655213b57e2f7218861f281ad</gtr:id><gtr:otherNames>Wimmer P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-9232</gtr:issn><gtr:outcomeId>GYzBXJ1N74u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>057E0F3C-8CAF-44F5-AC10-7E188F9995AA</gtr:id><gtr:title>The spatial organization of DNA virus genomes in the nucleus.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>544e61f78f6562.77735999</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BDE0CF3B-3084-457C-8EEC-74AF36A0495F</gtr:id><gtr:title>Regulation of alphaherpesvirus infections by the ICP0 family of proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c19030c4c6aab80249e86abb989dc5"><gtr:id>86c19030c4c6aab80249e86abb989dc5</gtr:id><gtr:otherNames>Boutell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>pm_13522_22_23239572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D6D559E-D6F9-4189-AAB9-E431E80C2E81</gtr:id><gtr:title>Depletion of CoREST does not improve the replication of ICP0 null mutant herpes simplex virus type 1.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>n1iBUan2gzX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEFFC364-47C6-482A-AE1C-E842876CFAD1</gtr:id><gtr:title>Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58112def9b9e7efed07f0472a59d7545"><gtr:id>58112def9b9e7efed07f0472a59d7545</gtr:id><gtr:otherNames>Vanni E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13522_22_22438555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46B94EAA-2EA1-4F72-992C-13A6EC97EAB2</gtr:id><gtr:title>STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>7DF2B7C4B61</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17D065DC-AD0E-4124-9667-E2B1CCB972DA</gtr:id><gtr:title>Interactions between DNA viruses, ND10 and the DNA damage response.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>B7CE47E87A1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>891BB172-578C-4514-919E-1AB7F87D45A3</gtr:id><gtr:title>A viral E3 ligase targets RNF8 and RNF168 to control histone ubiquitination and DNA damage responses.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0163656c5a6d8dd256ac7fa3d6835c52"><gtr:id>0163656c5a6d8dd256ac7fa3d6835c52</gtr:id><gtr:otherNames>Lilley CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>EaUsmWsr2b2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC3D06BD-7C22-422B-B35D-6F2E552DBFA5</gtr:id><gtr:title>The replication defect of ICP0-null mutant herpes simplex virus 1 can be largely complemented by the combined activities of human cytomegalovirus proteins IE1 and pp71.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13522_22_23135716</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8EE45FC4-7F54-4088-9E3E-73AB0D1465D2</gtr:id><gtr:title>PML and PML nuclear bodies: implications in antiviral defence.</gtr:title><gtr:parentPublicationTitle>Biochimie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-9084</gtr:issn><gtr:outcomeId>3C22001FBC0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0FD107D-B9EF-48E9-BE8D-9139648AB9D1</gtr:id><gtr:title>Sequences related to SUMO interaction motifs in herpes simplex virus 1 protein ICP0 act cooperatively to stimulate virus infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>544e61f80fb596.74188943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>812DEDA9-3659-468B-88EB-D89C73252BD6</gtr:id><gtr:title>Interplay between viruses and host sumoylation pathways.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>pm_13522_22_23624814</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16BD3D28-531C-4C81-A4FF-AB1484362B75</gtr:id><gtr:title>Herpes simplex virus type 1 genomes are associated with ND10 nuclear substructures in quiescently infected human fibroblasts.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>780D5E78A0F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAE20D1D-801B-474F-9207-B05FAB9F68B5</gtr:id><gtr:title>SUMO pathway dependent recruitment of cellular repressors to herpes simplex virus type 1 genomes.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17370cbcd6466978866cd94d29334473"><gtr:id>17370cbcd6466978866cd94d29334473</gtr:id><gtr:otherNames>Cuchet-Louren?o D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>rCd9XSKJcXu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63B6EBE6-DDCE-46CB-B3A0-F216E2F1686A</gtr:id><gtr:title>A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c19030c4c6aab80249e86abb989dc5"><gtr:id>86c19030c4c6aab80249e86abb989dc5</gtr:id><gtr:otherNames>Boutell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>M1ig7xoPtud</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C075F9C-2063-4368-9BCE-CFE9BE454D82</gtr:id><gtr:title>PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>3CE3ACE35F0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84DCA652-9223-4ECB-A606-21D6A1B1086E</gtr:id><gtr:title>Analysis of the SUMO2 Proteome during HSV-1 Infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe112e99fd87cc5c492a6b212ce5f6f0"><gtr:id>fe112e99fd87cc5c492a6b212ce5f6f0</gtr:id><gtr:otherNames>Sloan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5675e9311f2cc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F13F4C65-C313-4B46-BA59-1688C9CCBAB0</gtr:id><gtr:title>Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c19030c4c6aab80249e86abb989dc5"><gtr:id>86c19030c4c6aab80249e86abb989dc5</gtr:id><gtr:otherNames>Boutell C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>01C534166AD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1D612E0-8A31-4582-B345-75F8A72B59BF</gtr:id><gtr:title>Impact of the interaction between herpes simplex virus type 1 regulatory protein ICP0 and ubiquitin-specific protease USP7 on activation of adeno-associated virus type 2 rep gene expression.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/971efea1b632c44e44d1c171513b66da"><gtr:id>971efea1b632c44e44d1c171513b66da</gtr:id><gtr:otherNames>Geoffroy MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>BA2785ABE38</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8523AC1E-D994-4C08-B62F-0BA8BB5ADE2D</gtr:id><gtr:title>Control of human adenovirus type 5 gene expression by cellular Daxx/ATRX chromatin-associated complexes.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1de29dafdf8bfc5c0e634ba4d3807ba2"><gtr:id>1de29dafdf8bfc5c0e634ba4d3807ba2</gtr:id><gtr:otherNames>Schreiner S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>pm_13522_22_23396441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2E19AE3-C6E7-4FC5-9B05-C733C198C0F6</gtr:id><gtr:title>PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e381c74fcb955e21ca024f067c2592e8"><gtr:id>e381c74fcb955e21ca024f067c2592e8</gtr:id><gtr:otherNames>Cuchet D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>cVzGr9gqnMu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BDA18F7-886F-4F69-BD5F-4729EA960CB3</gtr:id><gtr:title>Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1de29dafdf8bfc5c0e634ba4d3807ba2"><gtr:id>1de29dafdf8bfc5c0e634ba4d3807ba2</gtr:id><gtr:otherNames>Schreiner S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>QhtCuZsXS4v</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9778F0EF-6DEF-407E-BB75-4A5CD743B419</gtr:id><gtr:title>The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17370cbcd6466978866cd94d29334473"><gtr:id>17370cbcd6466978866cd94d29334473</gtr:id><gtr:otherNames>Cuchet-Louren?o D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13522_22_24089555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96DB43C0-4BC5-4562-91E7-317B3DC77D40</gtr:id><gtr:title>The use of fluorescence microscopy to study the association between herpesviruses and intrinsic resistance factors.</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>pm_13522_22_22355446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A0BB562-E7FD-499C-B9F1-C4429CF8B2F4</gtr:id><gtr:title>Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome.</gtr:title><gtr:parentPublicationTitle>Proteomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2723c12ff0727de67ab75d967fb86e8"><gtr:id>d2723c12ff0727de67ab75d967fb86e8</gtr:id><gtr:otherNames>Antrobus R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1615-9853</gtr:issn><gtr:outcomeId>EF2AE0CFBD7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A48CF51F-2A84-45C7-B461-4F4228E1C9A2</gtr:id><gtr:title>Herpes simplex virus type 1 regulatory protein ICP0 aids infection in cells with a preinduced interferon response but does not impede interferon-induced gene induction.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb4eb49c160fb66c372318dbd0fb5edb"><gtr:id>bb4eb49c160fb66c372318dbd0fb5edb</gtr:id><gtr:otherNames>Everett RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>0BE0BA00BD8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B253393-2971-4F28-9722-09B8CB7521D4</gtr:id><gtr:title>Herpes simplex virus type 1 ICP0 localizes in the stromal layer of infected rabbit corneas and resides predominantly in the cytoplasm and/or perinuclear region of rabbit keratocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbc0bdd7388466577b1134239e8ffe2a"><gtr:id>fbc0bdd7388466577b1134239e8ffe2a</gtr:id><gtr:otherNames>Morishige N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>920E253A9A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AA9125A-A886-4D56-85D4-225D47732C71</gtr:id><gtr:title>Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe2678acdbf4bea4a3b4151a9ef32224"><gtr:id>fe2678acdbf4bea4a3b4151a9ef32224</gtr:id><gtr:otherNames>Morris JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>88EE33DF4A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7322F982-B8BF-45B9-9257-CD5E427CFD45</gtr:id><gtr:title>Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I and induces its SUMO-independent degradation.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17370cbcd6466978866cd94d29334473"><gtr:id>17370cbcd6466978866cd94d29334473</gtr:id><gtr:otherNames>Cuchet-Louren?o D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_13522_22_22875967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>361D74C6-E2A0-472D-BC66-42D0B0C34354</gtr:id><gtr:title>Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0174e08fa5793d8eb306670cc319622b"><gtr:id>0174e08fa5793d8eb306670cc319622b</gtr:id><gtr:otherNames>Lukashchuk V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>ENbARwWFTFB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U130169966</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>